US Home Diagnostics for Urinary Tract Infection Market is expected to reach US$ 444.91 Mn in 2027
Published Date : 26/08/2020

Report : US Home Diagnostics for Urinary Tract Infection Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Form Type (Dipsticks, Cups, Dipslides, Cassettes, and Others) and Distribution Channel (Retail Pharmacies & Drug Stores, Supermarkets/Hypermarkets, and Online Pharmacies)

Dipsticks Segment to Lead US Home Diagnostics for Urinary Tract Infection Market Growth during 2020–2027

According to our new market research study of “US Home Diagnostics For Urinary Tract Infection Forecast to 2027 - COVID-19 Impact and Analysis by Form Type and Distribution Channel,” the market is projected to reach US$ 444.91 million by 2027 from US$ 267.44 million in 2019; it is expected to grow at a CAGR of 6.7% from 2020 to 2027. The report highlights trends prevailing in the US home diagnostics for urinary tract infection market and the factors driving market along with those hindering it.

Based on form type, the US home diagnostics for urinary tract infection market is segmented into dipsticks, cup, dipslide, cassette, and others. In 2019, the dipsticks segment held the largest share of the market, and it is anticipated to register the highest CAGR during the forecast period. The growth of the market for this segment is attributed to its adoption for urinalysis. Advantages such as easy procedure, comprehensive analysis, product availability, and no adverse reactions drive the adoption of dipsticks. Moreover, increasing focus on product upgrading, coupled with growing number of product launches, is also anticipated to drive the adoption of dipsticks during the forecast period. For instance, in May 2018, Quantimetrix launched Dipper POCT Single-Use Liquid Urinalysis Dipstick Control. The newly launched dipstick has improved performance, efficiency, and compliance with a single dipstick. 

The growing prevalence of urinary tract infections and rise in aging population are the major enablers of the growth US home diagnostics for urinary tract infection market. However, the inaccuracy of UTI home screening test is the major factor hindering its market growth.

i-Health, Inc (AZO), F. Hoffmann-La Roche AG (Roche Holding AG), Acon Laboratories, Inc., Becton Dickinson and Company, Arkray Inc., Pathnostics, Abbott Laboratories, AytuBioScience, Inc. (Innovus Pharmaceuticals, Inc), Teco Diagnostics, and Scanwell Healthr are among the leading companies operating in the US home diagnostics for urinary tract infection market. 

 

US Home Diagnostics For Urinary Tract Infection Market, 2019–2027

 

The report segments in US home diagnostics for urinary tract infection market as follows:

By Form Type

  • Dipsticks
  • Cup
  • DipssSlide
  • Cassette
  • Others

By Distribution Channel

  • Retail Pharmacies & Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies
DOWNLOAD PDF BROCHURE